Performance

Health Plan :: Little differentiation between insurers in utilization and quality measures

Today, the Director of Health and the Health Insurance Commissioner jointly released the eighth annual publication of the Rhode Island Health Plans? Performance Report . This Report, based on 2005 submissions to the National Committee for Quality Assurance (NCQA), provides information on 29 separate measures covering 7 dimensions of performance (i.e., enrollment, utilization, prevention, screening, treatment, access, and satisfaction). Health plan performance is both trended over time and compared to regional and national averages.

Ecology :: Climate change threatens wild relatives of key crops

Wild relatives of plants such as the potato and the peanut are at risk of extinction, threatening a valuable source of genes that are necessary to boost the ability of cultivated crops to resist pests and tolerate drought, according to a new study released today by scientists of the Consultative Group on International Agricultural Research (CGIAR). The culprit is climate change, the researchers said.

Obesity :: Healthy body weight throughout adulthood may help delay disability

Maintaining a healthy body weight throughout adulthood may help prevent or delay the onset of physical disability as we age, according to researchers from Wake Forest University School of Medicine and colleagues.

Neurology :: Nanomedicine opens the way for nerve cell regeneration

The ability to regenerate nerve cells in the body could reduce the effects of trauma and disease in a dramatic way.

Sleep :: Start school later in the morning, say sleepy teens

A survey of sleep-deprived teens finds they think that a later start time for school and tests given later in the school day would result in better grades.

HIV :: Abbott’s HIV-1 Viral Load Test Approved by FDA for Use on New m2000 Molecular Diagnostics Instrument

Abbott (NYSE: ABT) and Celera (NYSE:CRA), an Applera Corporation business, announced that Abbott has received U.S. Food and Drug Administration (FDA) approval to market the Abbott RealTime HIV-1 viral load test for use on the company?s m2000? automated instrument system.

Health Plan :: Little differentiation between insurers in utilization and quality measures

Ecology :: Climate change threatens wild relatives of key crops

Obesity :: Healthy body weight throughout adulthood may help delay disability

Neurology :: Nanomedicine opens the way for nerve cell regeneration

Sleep :: Start school later in the morning, say sleepy teens

HIV :: Abbott’s HIV-1 Viral Load Test Approved by FDA for Use on New m2000 Molecular Diagnostics Instrument

Brain :: NIH study tracks brain development in some 500 children across US

Terrorism :: UN officials urge countries to act on counter-terrorism strategy

Cholesterol :: Women less likely than men to have their cholesterol controlled

Brain Tumor :: Radiosurgery allows Doug Fieger of Knack to perform while battling brain tumors